The involvement of Naplus-Kplus-ATPase in the development of platelet procoagulant response

• Autorzy: Tomasiak M. , Stelmach H. , Rusak T. , Ciborowski M. , Radziwon P.
• Języki publikacji: EN

Abstrakty

EN

In circulation, platelets may come into contact with both exogenous (cardiac glycoside treatment) and endogenously produced inhibitors of Na+/K+-ATPase. We examined whether blocking of platelet Na+/K+-ATPase by ouabain results in generation of procoagulant activity. It was shown that an in vitro treatment of platelets with ouabain (20-200 µM for 20 to 60 min) is associated with an intracellular accumulation of sodium ([Na+]i), generation of a weak calcium signal, and expression of procoagulant activity. The ouabain-induced procoagulant response was dose- and time-related, less pronounced than that evoked by collagen and similar to that produced by gramicidin, not affected by EDTA or aspirin, and strongly reduced in the absence of extracellular Na+ or by hyperosmolality. Flow cytometry studies revealed that ouabain treatment results in a unimodal left shift in the forward and side scatter of the entire platelet population indicating morphological changes of the plasma membrane. The shift was dose related, weaker than that evoked by collagen and similar to that produced by gramicidin. Ouabain-treated platelets express phosphatidylserine (PS). The ouabain-evoked PS expression was dose- and time-dependent, weaker than that produced by collagen and similar to that evoked by gramicidin. Electronic cell sizing measurements showed a dose-dependent increase in mean platelet volume upon treatment with ouabain. Hypoosmotically-evoked platelet swelling resulted in the appearance of procoagulant activity. Thromboelastography measurements indicate that, in whole blood, nanomolar (50-1000 nM, 15 min) concentrations of ouabain significantly accelerate the rate of clot formation initiated by contact and high extracellular concentration of calcium. We conclude that inefficiently operating platelet Na+/K+-ATPase results in a rise in [Na+]i. An increase in [Na+]i and the swelling associated with it may produce PS exposure and a rise in membrane curvature leading to the generation of a procoagulant activity.

Słowa kluczowe

EN

cytoplasmic pH; cardiac glycoside; animal cell; platelet activation; membrane enzyme; procoagulant activity; plasma membrane; calcium; sodium; potassium; ATPase; atrial fibrillation; platelet

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2007
• Tom: 54
• Numer: 3
• Opis fizyczny: p.625-639,fig.,ref.

Twórcy

autor

Tomasiak M.

• Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland

autor

Stelmach H.

autor

Rusak T.

autor

Ciborowski M.

autor

Radziwon P.

Bibliografia

• Aviv A (1992) The roles of cell Ca2+, protein kinase C and the Na+-H+ antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol 3: 1049–1063.
• Bath P, Algert Ch, Chapman N, Neal B, Group C (2004) Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35: 622–626.
• Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA (1998) Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. J Pharmacol Exp Therap 285: 1317–1326.
• Blanco G, Mercer R (1998) Isozymes of the Na+-K+-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 275: F633–F650.
• Blaustein MP (1993) Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. Am J Physiol 264: C1367–C1387.
• Blaustein MP, Lederer WJ (1999) Sodium/calcium exchange: its physiological implications Physiol Rev 79: 763–854.
• Bode AP, Hickerson DHM (2000) Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets 11: 259–271.
• Borin M, Siffert W (1990) Stimulation by thrombin increases the cytosolic free Na+ concentration in human platelets. Studies with the novel fluorescent cytosolic Na+ indicator sodium–binding benzofuran isophtalate. J Biol Chem 265: 19543–19550.
• Borin M, Siffert W (1991) Further characterization of the mechanisms mediating the rise in cytosolic free Na+ in thrombin stimulated platelets. Evidence for inhibition of Na+,K+-ATPase and for Na+ entry via a Ca2+ influx pathway. J Biol Chem 266: 13153–13160.
• Bork T, Mrsny RJ (1993) Appearance of additional ouabain binding sites on platelet surfaces following activation. Exp Cell Res 208: 189–196.
• Chandler WL (1995) The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 21 (Suppl 4): 1–6.
• Coller SB (1992) Platelets in cardiovascular thrombosis and thrombolysis. In The heart and Cardiovascular System (Fozzard HA et al., eds) pp 219–273. Raven Press Ltd, New York.
• Courageot MP, Lepine S, Hours M, Giraud F, Sulpice JC (2004) Involvement of sodium in early phosphatidylserine exposure and phospholipid scrambling induced by P2X7 purinoceptor activation in thymocytes. J Biol Chem 279: 21815–21823.
• Choudhury A, Chung I, Blann AD, Lip GY (2007) Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of “healthy control subjects” and “disease control subjects” in sinus rhythm. J Am Coll Cardiol 49: 1957–1964.
• Daleke DL (2003) Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 44: 233–242.
• Davie EW (2003) A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem 278: 50819–50832.
• de Jong K, Larkin SK, Styles LA, Bookchin RM, Kuypers FA (2001) Characterization of the phosphatidylserineexposing subpopulation of sickle cells. Blood 98: 860–867.
• Dimitrieva RI, Doris PA (2002) Cardiotonic steroids: potential endogenous sodium pump ligands with diverse function. Exp Biol Med 227: 561–569.
• el-Masri MA, Clark BJ, Qazzaz HM, Valdes R (2002) Human adrenal cells in culture produce both ouabainlike factors Clin Chem 48: 1720–1730.
• Ferrandi M, Manunta P, Rivera R (1998) Role of ouabain factor and Na+-K+ pump in rat and human genetic hypertension. Clin Exp Hypertens 20: 629–639.
• Flaumenhaft R (2003) Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol 23: 1152–1160.
• Fritz M, Radmacher M, Gauub HE (1994) Granula motion and membrane spreading during activation of human platelets imaged by atomic force microscopy. Biophys J 66: 1328–1334.
• Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH (1991) Identification and characterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259–6263.
• Heemskerk J, Bevers E, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88: 186–193.
• Hoffman JS, Wickrema A, Potapova O, Milanick M, Yingst DR (2002) Na+ pump isoforms in human erythroid progenitor cells and mature erythrocytes. Proc Natl Acad Sci USA 99: 14572–14577.
• Kamath S, Blann AD, Lip GYH (2001) Platelets and atrial fibrillation. Eur Heart J 22: 2233–2242.
• Kawamura A, Guo J, Itagaki Y, Bell C, Wang Y, Haupert GT Jr, Magil S, Gallagher RT, Berova N, Nakanishi K (1999) On the structure of endogenous ouabain. Proc Natl Acad Sci USA 96: 6654–6659.
• Keuren JF, Wielders SJ, Ulrichts H, Hackeng T, Heemskerk JW, Deckmyn H, Bevers EM, Lindhout T (2005) Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through proteaseactivated receptor-1. Arterioscler Thromb Vasc Biol 25: 1499–1505.
• Koeppe RE, Andersen OS (1996) Engineering the gramicidin channel. Annu Rev Biomol Struct 25: 231–258.
• Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D (1998) Functional significance of cell volume regulatory mechanisms. Physiol Rev 78: 247–306.
• Lees A, Wilson J, Orchard C, Orchard M (1989) Ouabain enhances basal and stimulus-induced cytoplasmic calcium concentrations in platelets. Thromb Haemost 62: 1000–1005.
• Lopatin DA, Ailamazian EK, Dmitriewa RI, Shpen VM, Fedorov OV, Doris PA, Bagrov AY (1999) Circulating bufadienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 17: 1179–1187.
• Marx G, Blankenfeld A, Panet R, Grodetsky R (1992) Model for the regulation of platelet volume and responsiveness by the trans-membrane Na+ /K+-pump. J Cell Physiol 151: 249–254.
• Monroe DM, Hoffman M, Roberts HR (2002) Platelets and thrombin generation. Arterioscler Thromb Vasc 22: 1381–1389.
• Pettersen E, Hagberg IA, Lyberg T, Gjesdal K (2002) Do cardiac glycosides affect platelet function? A flow cytometric study in healthy volunteers. Eur J Clin Pharmacol 58: 181–186.
• Reed G, Fitzgerald M, Polgar J (2000) Molecular mechanisms of platelet exocytosis: insights into the “secrete” life of thrombocytes. Blood 15: 3334–3342.
• Reuter H, Henderson SA, Han T, Ross RS, Goldhaber JI, Philipson KD (2002) The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides. Circ Res 90: 305–308.
• Rosskopf D (1999) Sodium-hydrogen exchange and platelet function. J Thromb Thrombolys 8: 15–23.
• Rosskopf D, Morgenstern E, Scholz W, Osswald U, Siffert W (1991) Rapid determination of the elevated Na+/H+ exchange in platelets of patients with essential hypertension using an optical swelling assay. J Hypertens 9: 231–238.
• Rota S, Flynn PD, Wareham NJ, Baglin TP (1996) Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin? Thromb Res 83: 329–338.
• Roth GJ, Calverley DC (1994) Aspirin, platelets, and thrombosis: theory and practice. Blood 83: 885–898.
• Salooja N, Perry DJ (2001) Thrombelastography. Blood Coagul Fibrinolysis 25: 327–337.
• Samson J, Stelmach H, Tomasiak M (2001) The importance of Na+/H+ exchanger for the generation of procoagulant activity by porcine blood platelets. Platelets 12: 436–442.
• Schoner W (2002) Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Bioch 269: 2440–2448.
• Shi J, Heegaard ChW, Rasmussen JT, Gilbert GE (2004) Lactadherin binds selectively to membranes containing phosphatidyl-l-serine and increased curvature. Biochim Biophys Acta 1667: 82–90.
• Sims PJ, Wiedmer T (2001) Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 86: 266–275.
• Stelmach H, Rusak T, Tomasiak M (2002) The involvement of Na+/H+ exchanger in formation of microvesicles by porcine platelets. Haematologia 239: 239–253.
• Stengelin MK, Hoffman JF (1997) Na+,K+-ATPase subunit isoforms in human reticulocytes: Evidence from reverse transcription-PCR for the presence of α1, α3, β2, β3 and γ. Proc Natl Acad Sci USA 94: 5943–5948.
• Straub SG, Daniel S, Sharp GWG (2002) Hyposmotic shock stimulates insulin secretion by two distinct mechanisms. Studies with the βHC9 cell. Am J Physiol Endocrinol Metab 282: E1070–E1076.
• Tait JF, Gibson D, Fujikawa K (1989) Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 264: 7944–7949.
• Therien AG, Blostein R (2000) Mechanisms of sodium pump regulation. Am J Physiol 279: C541–C566.
• Tomasiak M, Stelmach H (2005) The involvement of Na+/ H+ exchanger in the generation of procoagulant activity by human platelets. Acta Biochim Polon 52 (Suppl.): 192.
• Tomasiak MM, Stelmach H, Bodzenta-Łukaszyk A, Tomasiak M (2004) Involvement of Na+/H+ exchanger in the desmopressin-induced platelet procoagulant response. Acta Biochim Polon 51: 773–788.
• Tomasiak M, Ciborowski M, Stelmach H (2005) The role of Na+/H+ exchanger in serotonin secretion from porcine blood platelets. Acta Biochim Polon 52: 811–822.
• Vakkuri O, Arnason SS, Pouta A, Voulteenaho O, Leppaluoto J (2000) Radioimmunoassay of plasma ouabain in healthy and pregnant individuals. J Endocrinol 165: 669–677.
• Wenker OC, Wojciechowski Z, Sheinbaum R, Zisman E (2000) Thromboelastography. Internet J Anesthesiol 1: 1–20.
• Wolfs JLN, Comfurius P, Rasmussen JT, Keuren JFW, Lindhout T, Zwaal RFA, Bevers EM (2005) Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 62: 1514–1525.
• Zhou Q, Zhao J, Wiedmer T, Sims PJ (2002) Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99: 4030–4038.
• Zwaal RFA, Schroit AJ (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 4: 1121–1132.